| Issuer | % of Class | Filed |
|---|---|---|
|
Indaptus Therapeutics, Inc.
13D/A
Amendment 3
INDP · 45339J105
|
6.5% |
10/21/2026
Event 10/16/2026
|
|
Indaptus Therapeutics, Inc.
13D/A
Amendment 2
INDP · 45339J105
|
8.4% |
6/26/2026
Event 6/24/2026
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.